HK1038920B - Improved chemical methods and pharmaceutical preparations - Google Patents

Improved chemical methods and pharmaceutical preparations Download PDF

Info

Publication number
HK1038920B
HK1038920B HK02100464.5A HK02100464A HK1038920B HK 1038920 B HK1038920 B HK 1038920B HK 02100464 A HK02100464 A HK 02100464A HK 1038920 B HK1038920 B HK 1038920B
Authority
HK
Hong Kong
Prior art keywords
omeprazole
process according
substituted
prepared
active substance
Prior art date
Application number
HK02100464.5A
Other languages
German (de)
English (en)
French (fr)
Chinese (zh)
Other versions
HK1038920A1 (en
Inventor
Erickson Magnus
Gustavsson Anders
Josefsson Lars
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26663439&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1038920(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE9803953A external-priority patent/SE9803953D0/xx
Priority claimed from SE9803952A external-priority patent/SE9803952D0/xx
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HK1038920A1 publication Critical patent/HK1038920A1/en
Publication of HK1038920B publication Critical patent/HK1038920B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
HK02100464.5A 1998-11-18 1999-11-15 Improved chemical methods and pharmaceutical preparations HK1038920B (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE9803953A SE9803953D0 (sv) 1998-11-18 1998-11-18 Improved chemical process
SE9803952A SE9803952D0 (sv) 1998-11-18 1998-11-18 Pharmaceutical formulation
SE9803952-2 1998-11-18
SE9803953-0 1998-11-18
PCT/SE1999/002093 WO2000028975A2 (en) 1998-11-18 1999-11-15 Improved chemical process and pharmaceutical formulation

Publications (2)

Publication Number Publication Date
HK1038920A1 HK1038920A1 (en) 2002-04-04
HK1038920B true HK1038920B (en) 2005-03-11

Family

ID=26663439

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02100464.5A HK1038920B (en) 1998-11-18 1999-11-15 Improved chemical methods and pharmaceutical preparations

Country Status (18)

Country Link
US (1) US6403616B1 (https=)
EP (1) EP1131316B1 (https=)
JP (1) JP4610086B2 (https=)
KR (1) KR100619200B1 (https=)
CN (1) CN100503598C (https=)
AT (1) ATE271556T1 (https=)
AU (1) AU770633B2 (https=)
BR (1) BR9915421A (https=)
CA (1) CA2347981C (https=)
DE (1) DE69918854T2 (https=)
DK (1) DK1131316T3 (https=)
ES (1) ES2222754T3 (https=)
HK (1) HK1038920B (https=)
IL (2) IL142629A0 (https=)
NO (1) NO321275B1 (https=)
NZ (1) NZ511169A (https=)
PT (1) PT1131316E (https=)
WO (1) WO2000028975A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2005082888A1 (en) * 2004-03-01 2005-09-09 Milen Merkez Ilac Endustrisi A.S. Process for the preparation of magnesium salt of omeprazole
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8779175B2 (en) 2004-10-25 2014-07-15 Synthonics, Inc. Coordination complexes, pharmaceutical solutions comprising coordination complexes, and methods of treating patients
US20060141054A1 (en) 2004-10-25 2006-06-29 Thomas Piccariello Metal coordinated compositions
US7799937B2 (en) 2004-10-25 2010-09-21 Synthonics, Inc. Metal coordinated compositions
AU2007266574A1 (en) * 2006-06-01 2007-12-06 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US20090280173A1 (en) * 2008-05-09 2009-11-12 Ishwar Chauhan Multilayer Omeprazole Tablets
EP3372080A3 (en) 2011-11-10 2018-10-17 Rotam Agrochem International Co., Ltd Herbicidal composition and method of using the same
WO2016174664A1 (en) 2015-04-29 2016-11-03 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76839A (en) * 1984-10-31 1988-08-31 Byk Gulden Lomberg Chem Fab Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
DE69127275T2 (de) * 1991-06-21 1998-03-12 Ilsan Ilac Ve Hammaddeleri San Neues galenisches Verfahren für Omeprazol enthaltende Pellets
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
SE9302395D0 (sv) 1993-07-09 1993-07-09 Ab Astra New pharmaceutical formulation
TNSN95062A1 (fr) * 1994-05-27 1996-02-06 Astra Ab Nouveaux derives dialkoxy-pyridinyle-benzimidazole
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
AUPN846496A0 (en) * 1996-03-05 1996-03-28 Research Laboratories Of Australia Pty Ltd Electronic printing for display technology
SE508669C2 (sv) * 1996-04-26 1998-10-26 Astra Ab Nytt förfarande
CN1134667C (zh) * 1996-05-17 2004-01-14 福姆法克特公司 微电子弹性接触元件
CN1128997C (zh) * 2001-01-04 2003-11-26 中国科学院南京土壤研究所 一种吸力平板的制作方法

Also Published As

Publication number Publication date
NO321275B1 (no) 2006-04-10
BR9915421A (pt) 2001-08-07
JP2002529497A (ja) 2002-09-10
NZ511169A (en) 2003-06-30
KR20010089474A (ko) 2001-10-06
CN100503598C (zh) 2009-06-24
EP1131316B1 (en) 2004-07-21
AU770633B2 (en) 2004-02-26
CA2347981C (en) 2010-05-04
PT1131316E (pt) 2004-10-29
ATE271556T1 (de) 2004-08-15
IL142629A0 (en) 2002-03-10
JP4610086B2 (ja) 2011-01-12
NO20012427D0 (no) 2001-05-16
NO20012427L (no) 2001-07-09
DE69918854D1 (de) 2004-08-26
IL142629A (en) 2007-12-03
US6403616B1 (en) 2002-06-11
WO2000028975A2 (en) 2000-05-25
WO2000028975A3 (en) 2000-08-10
CA2347981A1 (en) 2000-05-25
KR100619200B1 (ko) 2006-09-05
CN1326455A (zh) 2001-12-12
HK1038920A1 (en) 2002-04-04
DE69918854T2 (de) 2005-07-21
AU1901700A (en) 2000-06-05
EP1131316A2 (en) 2001-09-12
ES2222754T3 (es) 2005-02-01
DK1131316T3 (da) 2004-09-27

Similar Documents

Publication Publication Date Title
US6605303B1 (en) Oral pharmaceutical extended release dosage form
AU778158B2 (en) New formulation
ES2208775T3 (es) Formas de dosificacion efervescentes de multiples unidades que comprenden inhibidor de la bomba de protones.
RU2166935C2 (ru) Таблетированная многоединичная лекарственная форма, способ ее получения, способ ингибирования секреции желудочной кислоты или лечения желудочно-кишечных заболеваний у млекопитающих и человека
KR100405586B1 (ko) 신규한제약제형및이의제조방법
EP1131316B1 (en) Improved chemical process and pharmaceutical formulation
CA2320963A1 (en) R-lansoprazole compositions and methods
KR20040079906A (ko) 산성 매체에 불안정한 벤지미다졸 화합물을 포함하는장용피(腸溶皮) 경구 정제 약형
ZA200103340B (en) Improved chemical process and pharmaceutical formulation.
MXPA00005896A (en) Oral pharmaceutical extended release dosage form
HK1008298B (en) Multiple unit pharmaceutical preparation containing proton pump inhibitor

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161115